nach oben

Drug Safety

Erschienen in:

01.03.2018 | Letter to the Editor

Comment on: “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”

verfasst von: Mona Kargar, Alireza Ahmadvand, Kheirollah Gholami

Erschienen in: Drug Safety | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

We read with interest the recent study by Nair et al. [1] about adverse drug reaction (ADR)-related hospitalizations in elderly Australians. …

Nair NP, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM, Connolly M, et al. Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two tasmanian hospitals. Drug Saf. 2017;40(7):597–606.CrossRef

Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36(1):58–66.CrossRef

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.CrossRefPubMed

Seger D, Barker K, McNaughton C. Misuse of the Naranjo adverse drug reaction probability scale in toxicology. Clin Toxicol. 2013;51(6):461–6.CrossRef

Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–9.CrossRefPubMed

Nair NP, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR. Hospitalization in older patients due to adverse drug reactions—the need for a prediction tool. Clin Interv Aging. 2016;11:497.CrossRef

Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–9.CrossRefPubMedPubMedCentral

Titel: Comment on: “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”
verfasst von: Mona Kargar
Alireza Ahmadvand
Kheirollah Gholami
Publikationsdatum: 01.03.2018
Verlag: Springer International Publishing
Erschienen in: Drug Safety / Ausgabe 3/2018
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI: https://doi.org/10.1007/s40264-017-0612-4

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Comment on: “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors

Neuropsychiatric Events Associated with Leukotriene-Modifying Agents: A Systematic Review

Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System

Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study

Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England

Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia